Latest Balance Sheet News

Cromwell Property Group has agreed to sell its 50% stake in a prime Chatswood property for $87 million, aiming to boost FY2026 earnings and reduce debt levels.

Cue Energy Resources reports steady production with a 29% increase in Australian cash receipts and a major milestone at its Maari field, signaling growth and resilience amid operational challenges.

Capricorn Metals has announced a definitive plan to acquire Warriedar Resources, consolidating key Western Australian gold assets and enhancing production capacity. The all-scrip deal offers Warriedar shareholders a 29% premium and positions Capricorn for a combined 9.1 million ounce gold equivalent resource.

Capricorn Metals has agreed to acquire Warriedar Resources in a court-approved all-share deal, expanding its Western Australian gold footprint and adding 2.3 million ounces gold equivalent to its resource base.

Sun Silver Limited has raised $30 million through a major institutional placement to accelerate drilling and development at its flagship Maverick Springs Silver-Gold Project in Nevada.

Waypoint REIT’s half-year update reveals a 3.4% portfolio valuation increase to $2.89 billion, alongside a strategic pause in its $50 million buyback program after $32.9 million in purchases.

Catalyst Metals reported steady gold production in the June 2025 quarter, progressing development at its Trident project while completing key corporate transactions that strengthen its growth outlook.

Future Battery Minerals Ltd has acquired 100% ownership of the Miriam Project, extinguishing royalties and advancing multiple high-priority gold targets with initial drilling completed. Assay results are expected in early September 2025.

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

Catalyst Metals has locked in a three-year A$100 million revolving credit facility with major banks, bolstering its financial flexibility without immediate debt drawdown. This move strengthens its balance sheet as it advances development at the Plutonic Gold Belt.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Macquarie Group Limited reported a 5% increase in FY25 profit to A$3.715 billion, declaring a higher dividend and announcing a key CFO transition. The group also outlined a strategic divestment and cautious outlook for FY26.